MDA - Market Direction Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : MDA - Market Direction Analysis

SPY 659.00

+1.0%

Nov 21 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: James Strauss who wrote (42719)	3/10/2000 11:02:00 AM
From: HairBall	Read Replies (1) of 99985

ATIS <----- A stock to take a look at. Advanced Tissue Says Patch Helps Grow Heart Blood Vessels (Dow Jones Online News, 03/10/2000 06:06) LA JOLLA, Calif. -(Dow Jones)- Advanced Tissue Sciences Inc. (ATIS) reported data showing its Dermagraft tissue-engineering product can stimulate blood vessel formation in the heart. The metabolically active, tissue-engineered epicardial patch secretes growth factors and matrix proteins. In a press release Friday, Advanced Tissue said preclinical studies conducted with researchers at the University of Arizona showed the Dermagraft patch could induce blood vessel formation to improve cardiac function. The company said blood vessels formed as early as 14 days after application of the product and the blood vessels matured over time. Dermagraft, in clinical use since 1991, is manufactured commercially and has demonstrated "a safe clinical profile" in wound-healing applications. Regards, LG

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next